Memphasys Ltd has released a press release.
Appendix 4E Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Correction to Outcome of Litigation
- Outcome of Litigation
- Felix Project development update
- Extension of Director line of credit
- SpermSep device development update
Later from Memphasys
- Adjusting amendment to Appendix 4E
- Advanced development of Felix device supported by R&D rebate
- $3.75M Capital Raising to Accelerate Dev of Felix Device
- $400,000 special grant offer from NSW Medical Devices Fund
- MEM Non-Renounceable Rights Issue Offer
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys